Form 4 holding
Director, 10%+ Owner
Athira Pharma, Inc.
- Security class
- Series A Warrant (right to buy)
- Shares / value
- 1,279,526
- Estimated value
- $8,124,990
- Report date
- 23 Dec 2025
- Price
- $6.35
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount